Guedes Y, Abgrall J F, Lebot M A, Voirin T, L'Azou D, Dheilly M, Tanguy R L, Le Garrec J
Therapie. 1989 Sep-Oct;44(5):323-6.
The aim of this study is to give to clinicians a well validated usefull tool allowing an increase of safety in the monitoring of netilmicin. During the first administration of the drug, two plasmatic concentrations are measured, and input in a preprogrammed hand-held calculator. A posology and a rythm of administration are returned by the calculator. After six days of this dosage regiment, the peak and the valley concentrations are compared with those previously given by the computer as values at equilibrium. No significant difference can be observed. There is no change in plasmatic creatinine level from the first to the sixth day of treatment. So, a preprogrammed hand-held computer can be convenient and safe to monitor netilmicin.
本研究的目的是为临床医生提供一种经过充分验证的有用工具,以提高奈替米星监测的安全性。在首次给药期间,测量两个血浆浓度,并输入预编程的手持计算器中。计算器会返回给药方案和给药节奏。在这个给药方案实施六天后,将峰浓度和谷浓度与计算机先前给出的平衡值进行比较。未观察到显著差异。从治疗的第一天到第六天,血浆肌酐水平没有变化。因此,预编程的手持计算机可方便、安全地用于监测奈替米星。